ID CAN2_BOVIN Reviewed; 700 AA. AC Q27971; A4IFD3; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 05-FEB-2008, sequence version 2. DT 24-JAN-2024, entry version 173. DE RecName: Full=Calpain-2 catalytic subunit; DE EC=3.4.22.53; DE AltName: Full=Calcium-activated neutral proteinase 2; DE Short=CANP 2; DE AltName: Full=Calpain M-type; DE AltName: Full=Calpain-2 large subunit; DE AltName: Full=Millimolar-calpain; DE Short=M-calpain; DE Flags: Precursor; GN Name=CAPN2; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Hereford; TISSUE=Ascending colon; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] OF 377-585. RC TISSUE=Skeletal muscle; RA Sun W., Bidwell C.A., Ji S., Hancock D.L.; RT "Cloning the partial cDNA's for the calpain family of protease genes from RT bovine muscle."; RL Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Calcium-regulated non-lysosomal thiol-protease which CC catalyzes limited proteolysis of substrates involved in cytoskeletal CC remodeling and signal transduction. Proteolytically cleaves MYOC at CC 'Arg-226'. Proteolytically cleaves CPEB3 following neuronal stimulation CC which abolishes CPEB3 translational repressor activity, leading to CC translation of CPEB3 target mRNAs. {ECO:0000250|UniProtKB:O08529, CC ECO:0000250|UniProtKB:P17655}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Broad endopeptidase specificity.; EC=3.4.22.53; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250}; CC Note=Binds 7 Ca(2+) ions. {ECO:0000250}; CC -!- ACTIVITY REGULATION: Activated by 200-1000 micromolar concentrations of CC calcium and inhibited by calpastatin. CC -!- SUBUNIT: Forms a heterodimer with a small (regulatory) subunit CC (CAPNS1). Interacts with CPEB3; this leads to cleavage of CPEB3. CC {ECO:0000250|UniProtKB:O08529, ECO:0000250|UniProtKB:Q07009}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane CC {ECO:0000250}. Note=Translocates to the plasma membrane upon Ca(2+) CC binding. {ECO:0000250}. CC -!- TISSUE SPECIFICITY: Ubiquitous. CC -!- SIMILARITY: Belongs to the peptidase C2 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAA18455.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC134526; AAI34527.1; -; mRNA. DR EMBL; U07850; AAA18455.1; ALT_FRAME; mRNA. DR RefSeq; NP_001096556.1; NM_001103086.1. DR AlphaFoldDB; Q27971; -. DR SMR; Q27971; -. DR CORUM; Q27971; -. DR IntAct; Q27971; 3. DR MINT; Q27971; -. DR STRING; 9913.ENSBTAP00000059970; -. DR BindingDB; Q27971; -. DR ChEMBL; CHEMBL3612; -. DR MEROPS; C02.002; -. DR PaxDb; 9913-ENSBTAP00000044733; -. DR PeptideAtlas; Q27971; -. DR Ensembl; ENSBTAT00000047532.4; ENSBTAP00000044733.3; ENSBTAG00000012778.6. DR GeneID; 281662; -. DR KEGG; bta:281662; -. DR CTD; 824; -. DR VEuPathDB; HostDB:ENSBTAG00000012778; -. DR VGNC; VGNC:55037; CAPN2. DR eggNOG; KOG0045; Eukaryota. DR GeneTree; ENSGT00940000154784; -. DR HOGENOM; CLU_010982_0_1_1; -. DR InParanoid; Q27971; -. DR OMA; ELNLVNW; -. DR OrthoDB; 142935at2759; -. DR TreeFam; TF314748; -. DR Reactome; R-BTA-1474228; Degradation of the extracellular matrix. DR Proteomes; UP000009136; Chromosome 16. DR Bgee; ENSBTAG00000012778; Expressed in myometrium and 105 other cell types or tissues. DR ExpressionAtlas; Q27971; baseline. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0030425; C:dendrite; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; ISS:UniProtKB. DR GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB. DR GO; GO:0006508; P:proteolysis; ISS:UniProtKB. DR CDD; cd00214; Calpain_III; 1. DR CDD; cd00044; CysPc; 1. DR CDD; cd16199; EFh_PEF_CAPN2; 1. DR Gene3D; 2.60.120.380; -; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 1. DR Gene3D; 1.10.238.10; EF-hand; 1. DR InterPro; IPR033883; C2_III. DR InterPro; IPR022684; Calpain_cysteine_protease. DR InterPro; IPR022682; Calpain_domain_III. DR InterPro; IPR022683; Calpain_III. DR InterPro; IPR036213; Calpain_III_sf. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR018247; EF_Hand_1_Ca_BS. DR InterPro; IPR002048; EF_hand_dom. DR InterPro; IPR042736; EFh_PEF_CAPN2. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR000169; Pept_cys_AS. DR InterPro; IPR001300; Peptidase_C2_calpain_cat. DR PANTHER; PTHR10183; CALPAIN; 1. DR PANTHER; PTHR10183:SF268; CALPAIN-2 CATALYTIC SUBUNIT; 1. DR Pfam; PF01067; Calpain_III; 1. DR Pfam; PF13833; EF-hand_8; 1. DR Pfam; PF00648; Peptidase_C2; 1. DR PRINTS; PR00704; CALPAIN. DR SMART; SM00720; calpain_III; 1. DR SMART; SM00230; CysPc; 1. DR SUPFAM; SSF49758; Calpain large subunit, middle domain (domain III); 1. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR SUPFAM; SSF47473; EF-hand; 1. DR PROSITE; PS50203; CALPAIN_CAT; 1. DR PROSITE; PS00018; EF_HAND_1; 2. DR PROSITE; PS50222; EF_HAND_2; 3. DR PROSITE; PS00139; THIOL_PROTEASE_CYS; 1. PE 2: Evidence at transcript level; KW Acetylation; Calcium; Cell membrane; Cytoplasm; Hydrolase; Membrane; KW Metal-binding; Protease; Reference proteome; Repeat; Thiol protease. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P17655" FT PROPEP 2..19 FT /note="Anchors to the small subunit" FT /evidence="ECO:0000255" FT /id="PRO_0000317423" FT CHAIN 20..700 FT /note="Calpain-2 catalytic subunit" FT /id="PRO_0000207702" FT DOMAIN 45..344 FT /note="Calpain catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00239" FT DOMAIN 572..597 FT /note="EF-hand 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 602..637 FT /note="EF-hand 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 652..672 FT /note="EF-hand 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT REGION 345..514 FT /note="Domain III" FT /evidence="ECO:0000250" FT REGION 515..529 FT /note="Linker" FT /evidence="ECO:0000250" FT REGION 530..700 FT /note="Domain IV" FT /evidence="ECO:0000250" FT ACT_SITE 105 FT /evidence="ECO:0000250" FT ACT_SITE 262 FT /evidence="ECO:0000250" FT ACT_SITE 286 FT /evidence="ECO:0000250" FT BINDING 91 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250" FT BINDING 96 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250" FT BINDING 175 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250" FT BINDING 229 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250" FT BINDING 230 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250" FT BINDING 292 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000250" FT BINDING 299 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000250" FT BINDING 323 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000250" FT BINDING 542 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000250" FT BINDING 545 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000250" FT BINDING 547 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000250" FT BINDING 552 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="5" FT /evidence="ECO:0000250" FT BINDING 585 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 587 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 589 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 591 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 596 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 615 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 617 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 619 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 621 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 626 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 658 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250" FT BINDING 661 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000250|UniProtKB:P17655" FT CONFLICT 417 FT /note="R -> Q (in Ref. 2; AAA18455)" FT /evidence="ECO:0000305" FT CONFLICT 460..462 FT /note="ERS -> DV (in Ref. 2; AAA18455)" FT /evidence="ECO:0000305" SQ SEQUENCE 700 AA; 79935 MW; 00FD932E9C6AB268 CRC64; MAGIAAKLAK DREAAEGLGS HERAVKYLNQ DYAALRDECL EAGALFQDPS FPALPSSLGF KELGPYSSKT RGIEWKRPTE ICDNPQFITG GATRTDICQG ALGDCWLLAA IASLTLNEEI LARVVPLDQS FQENYAGIFH FQFWQYGEWV EVVVDDRLPT KDGELLFVHS AEGSEFWSAL LEKAYAKING CYEALSGGAT TEGFEDFTGG IAEWYELRKA PPNLFRIIQK ALQKGSLLGC SIDITSAADS EAITFQKLVK GHAYSVTGAE EVESRGSLQK LIRIRNPWGE VEWTGQWNDN CPNWNTVDPE VRETLTRQHE DGEFWMSFND FLRHYSRLEI CNLTPDTLTS DSYKKWKLTK MDGNWRRGST AGGCRNYPNT FWMNPQYLIK LEEEDEDQED GESGCTFLVG LIQKHRRRQR KMGEDMHTIG FGIYEVPEEL TGQTNIHLSK KFFLTTRARE RSDTFINLRE VLNRFKLPPG EYIVVPSTFE PNKDGDFCIR VFSEKKADYQ VVDDEIEANI DEIDISEDDI DDGFRRLFAQ LAGEDAEISA FELQTILRRV LAKRQDIKSD GFSIETCKIM VDMLDSDGSG KLGLKEFYIL WTKIQKYQKI YREIDVDRSG TMNSYEMRKA LEEAGFKMPC QLHQVIVARF ADDDLIIDFD NFVRCLIRLE TLFRIFKQLD PENTGMIQLD LISWLSFSVL //